Literature DB >> 156192

Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia.

S Korth-Schutz, R Virdis, P Saenger, D M Chow, L S Levine, M I New.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 156192     DOI： 10.1210/jcem-46-3-452

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  15 in total

1.  Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  P W Speiser; J Dupont; D Zhu; J Serrat; M Buegeleisen; M T Tusie-Luna; M Lesser; M I New; P C White
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  High frequency of nonclassical steroid 21-hydroxylase deficiency.

Authors:  P W Speiser; B Dupont; P Rubinstein; A Piazza; A Kastelan; M I New
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

3.  Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia.

Authors:  I N Silva; C E Kater; C F Cunha; M B Viana
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

Review 4.  Management of congenital adrenal hyperplasia.

Authors:  I A Hughes
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

Review 5.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a review of current knowledge.

Authors:  G E Bacon; R P Kelch
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

6.  Effect of treatment on growth in congenital adrenal hyperplasia.

Authors:  O Ercan; S Hatemi; E Kutlu; N Turan
Journal:  Indian J Pediatr       Date:  2000-11       Impact factor: 1.967

7.  Management of 21-hydroxylase deficiency congenital adrenal hyperplasia: A survey of Canadian paediatric endocrinologists.

Authors:  Robert Stein; Diane Wherrett; Denis Daneman
Journal:  Paediatr Child Health       Date:  2005-07       Impact factor: 2.253

8.  17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.

Authors:  K von Schnakenburg; F Bidlingmaier; D Knorr
Journal:  Eur J Pediatr       Date:  1980-05       Impact factor: 3.183

9.  Daily profiles of salivary cortisol in hydrocortisone treated children with congenital adrenal hyperplasia.

Authors:  R Hampl; L Foretová; J Sulcová; L Stárka
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

10.  Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.

Authors:  H Frisch; K Parth; E Schober; W Swoboda
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.